BRAF and metastatic malignant neoplasm in the lymph nodes: The results showed that high-risk PTMC has similar characteristics in the expression of important molecular markers compared with those of LPTC, suggesting the pathogenesis of poor prognosis for the patients of PTMC with extrathyroidal invasion and/or lymph node metastasis and/or BRAF V600E mutation.